Table 2.
COVID-19 Total | COVID-19 with ANVD | COVID-19 without ANVD | P Value | |
---|---|---|---|---|
Total Number | 382 | 154 (40.3%) | 228(55%) | |
Male (N, %) | 203 (53.1%) | 79 (20.7%) | 124 (32.4%) | 0.55 |
Age (Years +/- SD) | 62.2 ±/- 16.8 | 58 ±/- 15.8 | 65 ±/- 16.9 | 0.0005 |
BMI(+/- SD) | 29.9 ±/- 8.5 | 31.5 ±/- 8.7 | 28 ±/- 8.2 | 0.0001 |
AA (N, %) | 272 (71.2%) | 104 (27.2%) | 168 (44%) | 0.2 |
Latinx (N, %) | 61 (15.9%) | 34 (8.9%) | 27 (7%) | 0.01 |
White (N, %) | 26 (6.8%) | 8 (2.1%) | 18 (4.7%) | 0.29 |
HTN (N, %) | 273 (71.5%) | 110 (28.8%) | 163 (42.7%) | 0.99 |
DM (N, %) | 171 (44.8%) | 69 (18%) | 102 (27%) | 0.99 |
CPD (N, %) | 87 (22.8%) | 38 (9.9%) | 49 (12.8%) | 0.47 |
AIDS (N, %) | 13 (3.4%) | 4 (1%) | 9 (2.4%) | 0.48 |
Cirrhosis (N, %) | 2 (0.5%) | 1 (0.25%) | 1 (0.25%) | 0.88 |
Legend
AA: African American, AIDS: Acquired immunodeficiency syndrome, ANVD: Abdominal pain, nausea, vomiting or diarrhea, CPD: Chronic pulmonary disease, DM: Diabetes mellitus, HTN: Hypertension, N: Number, SD: Standard deviation,